The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and tolerability of relugolix in combination with abiraterone or apalutamide for treatment of advanced prostate cancer: Data from a 52-week clinical trial.
 
Jose De La Cerda
Employment - Urology San Antonio
Honoraria - AstraZeneca; Dendreon; Foundation Medicine; Johnson & Johnson; Pfizer
Consulting or Advisory Role - AstraZeneca; Dendreon; Foundation Medicine; Johnson & Johnson; Pfizer
Speakers' Bureau - Foundation Medicine; Johnson & Johnson
Research Funding - Urology San Antonio
 
Laurence Belkoff
Consulting or Advisory Role - Johnson & Johnson/Janssen, Immunol Bayer
Research Funding - All monies for research to company. (Inst)
 
Kevin Courtney
Consulting or Advisory Role - Novartis
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Celgene/Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); DualityBio (Inst); Exelixis (Inst); Harpoon therapeutics (Inst); Janssen Research & Development (Inst); Lilly (Inst); Myovant Sciences (Inst); Novartis (Inst); Pfizer (Inst); Stemline Therapeutics (Inst); Surface Oncology (Inst)
Patents, Royalties, Other Intellectual Property - My spouse receives patent royalties from Athena Diagnostics, Inc. (I)
 
Elan Diamond
Employment - Summit Health
Honoraria - Bayer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Sanofi; Merck
Speakers' Bureau - Bayer; Myovant Sciences
 
James D'Olimpio
No Relationships to Disclose
 
Curtis Dunshee
Employment - Arizona Urology Specialists
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen Biotech; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Dendreon (Inst); ESSA (Inst); Janssen Oncology (Inst); pfizer (Inst); Sumitomo Pharma Oncology (Inst)
 
Lawrence Gervasi
No Relationships to Disclose
 
Michael Goodman
Honoraria - Curio Science; Targeted Oncology
Consulting or Advisory Role - Alexion Pharmaceuticals; Sanofi/Aventis
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Pfizer (Inst); Genentech (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Curio Science; Genentech
 
Kriti Mittal
Honoraria - Aptitude Health; Cardinal Health; IntrinsiQ; Medpage; Research to Practice; Research to Practice; Targeted Oncology; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; AVEO; Aveo; Curio Science; Dendreon; Janssen; Myovant Sciences
Research Funding - Pfizer
 
David Morris
Stock and Other Ownership Interests - UROGPO
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; Clovis Oncology; Decipher Biosciences; Dendreon; Janssen Oncology; Lantheus Medical Imaging; Merck Serono; Myovant Sciences; Myriad Genetics; Pfizer/EMD Serono; Urogen pharma; UROGPO
Speakers' Bureau - Astellas Medivation; AstraZeneca; Clovis Oncology; Janssen; Merck
Research Funding - Astellas Pharma (Inst); AstraZeneca/Merck (Inst); Bayer (Inst); Clovis Oncology (Inst); Dendreon (Inst); Exelixis (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer/Astellas (Inst); Urogen pharma (Inst)
 
Paul Sieber
Honoraria - Bayer; Foundation Medicine; Pfizer
Speakers' Bureau - Astellas Pharma; Bayer; Dendren; Janssen; Merck; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); CG Therapeutics (Inst); Dendreon (Inst); Jansn (Inst); Merck (Inst); ORIC Pharmaceuticals (Inst); Pfize (Inst)
Travel, Accommodations, Expenses - Astellas Scientific and Medical Affairs Inc; Bayer Germany; Dendreon; Merck; Pfizer/NCCN
 
Ronald Tutrone
Employment - Chesapeake Urology
Stock and Other Ownership Interests - Compass Therapeutics; GlaxoSmithKline; ImmnityBio; Myovant Sciences; Novartis; Nymox; Urogen pharma; Veru
Consulting or Advisory Role - Exosome Diagnostics; Myovant Sciences; Novartis; Nymox
Speakers' Bureau - Exosome Diagnostics; Medivation/Astellas; Pfizer
Research Funding - Advantagene (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); Blue Earth Diagnostics (Inst); Dendreon (Inst); ESSA (Inst); Exosome Diagnostics (Inst); Francis Medical (Inst); Genomic Health (Inst); Janssen Oncology (Inst); Lantheus Medical Imaging (Inst); Lilly (Inst); MDxHealth (Inst); Medivation/Astellas (Inst); Merck (Inst); POINT Biopharma (Inst); Propella Therapeutics (Inst); Veru (Inst)
 
Michael Ryan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Yi Zhong
Employment - Sumitomo Pharma Oncology
 
Mike Ufer
Employment - 16. Sumitomo Pharma Switzerland GmbH
 
Neal Shore
Employment - GenesisCare
Consulting or Advisory Role - Accord Research; Alessa Therapeutics; Amgen; Antev; Arquer Diagnostics; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Aura Biosciences; Bayer; Bioprotect; Bristol-Myers Squibb/Sanofi; CG Oncology; Clarity Pharmaceuticals; Dendreon; Exact Imaging; Ferring; Fize Medical; Glytherix; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myriad Genetics; Novartis; Peerview; Pfizer; Photocure; PlatformQ Health; Promaxo; Propella Therapeutics; Protara Therapeutics; Sanofi; Siemens; Speciality Networks; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tolmar; Tutelix; Urogen pharma
Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow